(JBTM) JBTMarel - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 6.875m USD | Total Return: 11.8% in 12m
Avg Turnover: 70.0M
Qual. Beats: 0
Rev. Trend: 85.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
JBT Marel Corporation, formerly John Bean Technologies Corporation, is a global provider of technology solutions for the food and beverage processing industries. Headquartered in Chicago, the company operates through two primary segments: Protein Solutions and Prepared Food and Beverage Solutions. Its portfolio includes a wide range of equipment and software for slaughtering, cooking, freezing, packaging, and high-pressure processing.
The company utilizes a diversified business model by serving end markets ranging from traditional poultry and beef to plant-based meat alternatives and pet foods. Furthermore, JBT Marel maintains a presence in the industrial automation sector by providing automated guided vehicle (AGV) systems for automotive, warehouse, and medical facilities. The food processing machinery sector is characterized by high barriers to entry due to the technical complexity of food safety regulations and the integration of proprietary software into production lines.
For a more detailed look at the companys financial health, you may wish to examine the metrics available on ValueRay.
The company distributes its products globally through a combination of a direct sales force and independent distributors. Following its name change in January 2025, JBT Marel remains a significant player in the Industrial Machinery & Supplies & Components sub-industry, focusing on the automation and optimization of global food supply chains.
- Marel merger integration synergies drive long term margin expansion and profitability
- Global poultry and protein demand volatility impacts capital equipment order backlogs
- Recurring aftermarket service revenue provides stability against cyclical food processing cycles
- High interest rates constrain customer capital expenditure on automated processing systems
- Shift toward plant based and convenience foods fuels specialized equipment sales
| Net Income: 167.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.28 > 1.0 |
| NWC/Revenue: 0.46% < 20% (prev 14.01%; Δ -13.55% < -1%) |
| CFO/TA 0.05 > 3% & CFO 426.3m > Net Income 167.5m |
| Net Debt (1.61b) to EBITDA (554.1m): 2.91 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.4m) vs 12m ago 1.35% < -2% |
| Gross Margin: 35.34% > 18% (prev 0.36%; Δ 3.50k% > 0.5%) |
| Asset Turnover: 48.01% > 50% (prev 27.22%; Δ 20.79% > 0%) |
| Interest Coverage Ratio: 3.83 > 6 (EBITDA TTM 554.1m / Interest Expense TTM 75.1m) |
| A: 0.00 (Total Current Assets 1.68b - Total Current Liabilities 1.66b) / Total Assets 8.16b |
| B: 0.18 (Retained Earnings 1.50b / Total Assets 8.16b) |
| C: 0.04 (EBIT TTM 287.6m / Avg Total Assets 8.08b) |
| D: 1.22 (Book Value of Equity 4.48b / Total Liabilities 3.68b) |
| Altman-Z'' = 2.13 = BBB |
| DSRI: 0.60 (Receivables 580.0m/543.9m, Revenue 3.88b/2.18b) |
| GMI: 1.01 (GM 35.34% / 35.76%) |
| AQI: 0.97 (AQ_t 0.70 / AQ_t-1 0.72) |
| SGI: 1.78 (Revenue 3.88b / 2.18b) |
| TATA: -0.03 (NI 167.5m - CFO 426.3m) / TA 8.16b) |
| Beneish M = -2.84 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 129.72 with a total of 546,686 shares traded.
Over the past week, the price has changed by +5.28%,
over one month by +1.43%,
over three months by -19.37% and
over the past year by +11.79%.
JBTMarel has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold JBTM.
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 178.8 | 37.8% |
P/E Forward = 16.8634
P/S = 1.7717
P/B = 1.5335
P/EG = 1.2201
Revenue TTM = 3.88b USD
EBIT TTM = 287.6m USD
EBITDA TTM = 554.1m USD
Long Term Debt = 1.43b USD (from longTermDebt, last quarter)
Short Term Debt = 411.0m USD (from shortTermDebt, last quarter)
Debt = 1.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.61b USD (calculated: Debt 1.84b - CCE 230.0m)
Enterprise Value = 8.49b USD (6.87b + Debt 1.84b - CCE 230.0m)
Interest Coverage Ratio = 3.83 (Ebit TTM 287.6m / Interest Expense TTM 75.1m)
EV/FCF = 26.80x (Enterprise Value 8.49b / FCF TTM 316.7m)
FCF Yield = 3.73% (FCF TTM 316.7m / Enterprise Value 8.49b)
FCF Margin = 8.16% (FCF TTM 316.7m / Revenue TTM 3.88b)
Net Margin = 4.32% (Net Income TTM 167.5m / Revenue TTM 3.88b)
Gross Margin = 35.34% ((Revenue TTM 3.88b - Cost of Revenue TTM 2.51b) / Revenue TTM)
Gross Margin QoQ = 35.15% (prev 34.53%)
Tobins Q-Ratio = 1.04 (Enterprise Value 8.49b / Total Assets 8.16b)
Interest Expense / Debt = 4.07% (Interest Expense 75.1m / Debt 1.84b)
Taxrate = 25.0% (15.0m / 60.0m)
NOPAT = 215.7m (EBIT 287.6m * (1 - 25.00%))
Current Ratio = 1.01 (Total Current Assets 1.68b / Total Current Liabilities 1.66b)
Debt / Equity = 0.41 (Debt 1.84b / totalStockholderEquity, last quarter 4.48b)
Debt / EBITDA = 2.91 (Net Debt 1.61b / EBITDA 554.1m)
Debt / FCF = 5.09 (Net Debt 1.61b / FCF TTM 316.7m)
Total Stockholder Equity = 4.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.07% (Net Income 167.5m / Total Assets 8.16b)
RoE = 3.78% (Net Income TTM 167.5m / Total Stockholder Equity 4.44b)
RoCE = 4.90% (EBIT 287.6m / Capital Employed (Equity 4.44b + L.T.Debt 1.43b))
RoIC = 3.14% (NOPAT 215.7m / Invested Capital 6.86b)
WACC = 8.35% (E(6.87b)/V(8.72b) * Re(9.77%) + D(1.84b)/V(8.72b) * Rd(4.07%) * (1-Tc(0.25)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 74.54 | Cagr: 24.08%
[DCF] Terminal Value 77.97% ; FCFF base≈273.1m ; Y1≈313.0m ; Y5≈460.7m
[DCF] Fair Price = 102.2 (EV 6.93b - Net Debt 1.61b = Equity 5.32b / Shares 52.1m; r=8.35% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.03 | # QB: 0
Revenue Correlation: 85.54 | Revenue CAGR: 37.90% | SUE: 0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.02 | Chg30d=-4.46% | Revisions=-50% | Analysts=6
EPS next Quarter (2026-09-30): EPS=2.32 | Chg30d=-1.89% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=8.28 | Chg30d=+0.97% | Revisions=+43% | GrowthEPS=+29.2% | GrowthRev=+6.1%
EPS next Year (2027-12-31): EPS=9.36 | Chg30d=+0.83% | Revisions=+33% | GrowthEPS=+13.0% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -50%